Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 3
1990 4
1991 1
1992 3
1993 4
1994 2
1995 2
1996 6
1997 2
1998 3
1999 1
2000 1
2001 1
2003 3
2007 2
2008 1
2009 1
2010 4
2011 10
2012 11
2013 7
2014 5
2015 4
2016 2
2017 9
2018 9
2019 10
2020 9
2021 16
2022 19
2023 16
2024 20
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Hernandez AF, et al. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2. Lancet. 2018. PMID: 30291013 Free article. Clinical Trial.
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes.
Cinti F, Leccisotti L, Sorice GP, Capece U, D'Amario D, Lorusso M, Gugliandolo S, Morciano C, Guarneri A, Guzzardi MA, Mezza T, Capotosti A, Indovina L, Ferraro PM, Iozzo P, Crea F, Giordano A, Giaccari A. Cinti F, et al. Among authors: giaccari a. Cardiovasc Diabetol. 2023 Dec 19;22(1):349. doi: 10.1186/s12933-023-02091-0. Cardiovasc Diabetol. 2023. PMID: 38115004 Free PMC article. Clinical Trial.
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk.
Fadini GP, Longato E, Morieri ML, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Lancet Reg Health Eur. 2024 Feb 1;38:100847. doi: 10.1016/j.lanepe.2024.100847. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38328413 Free PMC article.
Publish and perish.
Giaccari A. Giaccari A. Nutr Metab Cardiovasc Dis. 2017 Dec;27(12):1035-1036. doi: 10.1016/j.numecd.2017.11.002. Nutr Metab Cardiovasc Dis. 2017. PMID: 29198555 No abstract available.
Glucose toxicity.
Rossetti L, Giaccari A, DeFronzo RA. Rossetti L, et al. Among authors: giaccari a. Diabetes Care. 1990 Jun;13(6):610-30. doi: 10.2337/diacare.13.6.610. Diabetes Care. 1990. PMID: 2192847 Review.
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study.
Bonora BM, Russo G, Leonetti F, Strazzabosco M, Nollino L, Aimaretti G, Giaccari A, Broglio F, Consoli A, Avogaro A, Fadini GP; GLIMPLES Study Investigators. Bonora BM, et al. Among authors: giaccari a. J Endocrinol Invest. 2024 Jun;47(6):1395-1403. doi: 10.1007/s40618-024-02309-2. Epub 2024 Feb 18. J Endocrinol Invest. 2024. PMID: 38369592 Free PMC article.
171 results